Gilead Sciences (GILD) closed at $112.69 in the latest trading session, marking a +1.93% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw an upswing of 0.51%, while the tech-heavy Nasdaq depreciated by 0.28%. The stock of HIV and hepatitis C drugmaker has fallen by 1.96% in the past month, lagging the Medical sector's gain of 4.67% and the S&P 500's gain of 4.83%.The investment community will be paying close attention to the earnings perform ...